147 related articles for article (PubMed ID: 37497579)
1. Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study.
Vossler DG; Rosenfeld WE; Stern S; Wade CT; Ferrari L; Kerr WT; Wechsler R
Epilepsia; 2023 Oct; 64(10):2644-2652. PubMed ID: 37497579
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Sperling MR; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Klein P; Krauss GL; Vossler DG; Wechsler R; Ferrari L; Grall M; Rosenfeld WE
Epilepsia; 2021 Dec; 62(12):3005-3015. PubMed ID: 34633084
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study.
O'Dwyer R; Stern S; Wade CT; Guggilam A; Rosenfeld WE
Drugs Aging; 2024 Mar; 41(3):251-260. PubMed ID: 38446341
[TBL] [Abstract][Full Text] [Related]
4. Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency.
Aboumatar S; Biton V; Wechsler R; Ferrari L; Rosenfeld WE
Epilepsy Res; 2022 Oct; 186():107014. PubMed ID: 36063589
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study.
Abou-Khalil B; Aboumatar S; Klein P; Krauss GL; Sperling MR; Rosenfeld WE
Epilepsy Res; 2022 Aug; 184():106952. PubMed ID: 35671632
[TBL] [Abstract][Full Text] [Related]
6. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Rosenfeld WE; Nisman A; Ferrari L
Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
[TBL] [Abstract][Full Text] [Related]
9. Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
Aboumatar S; Ferrari L; Stern S; Wade CT; Weingarten M; Connor GS; Rosenfeld WE
Epilepsy Res; 2024 Feb; 200():107306. PubMed ID: 38340681
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study.
Rosenfeld WE; Ferrari L; Kamin M
Epilepsy Res; 2022 Jul; 183():106940. PubMed ID: 35605481
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures.
Chung SS; French JA; Kowalski J; Krauss GL; Lee SK; Maciejowski M; Rosenfeld WE; Sperling MR; Mizne S; Kamin M
Neurology; 2020 Jun; 94(22):e2311-e2322. PubMed ID: 32409485
[TBL] [Abstract][Full Text] [Related]
12. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
Sperling MR; Klein P; Aboumatar S; Gelfand M; Halford JJ; Krauss GL; Rosenfeld WE; Vossler DG; Wechsler R; Borchert L; Kamin M
Epilepsia; 2020 Jun; 61(6):1099-1108. PubMed ID: 32396252
[TBL] [Abstract][Full Text] [Related]
13. Onset of efficacy and adverse events during Cenobamate titration period.
Steinhoff BJ; Ben-Menachem E; Brandt C; García Morales I; Rosenfeld WE; Santamarina E; Serratosa JM
Acta Neurol Scand; 2022 Sep; 146(3):265-275. PubMed ID: 35711112
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
Varughese RT; Shah YD; Karkare S; Kothare SV
Epilepsy Behav; 2022 May; 130():108679. PubMed ID: 35381496
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Del Giovane C; Silvestrini M; Brigo F
CNS Drugs; 2020 Nov; 34(11):1105-1120. PubMed ID: 32851590
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.
Brandt C; Sánchez-Álvarez JC; Steinhoff BJ; Milanov I; Serratosa JM
Seizure; 2022 Mar; 96():86-93. PubMed ID: 35168142
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study.
Lattanzi S; Ranzato F; Di Bonaventura C; Bonanni P; Gambardella A; Tartara E; Assenza G; Procaccini M; Falsetto N; Villano V; Camattari G; Ori A; Di Gennaro G;
Neurol Ther; 2024 Jun; ():. PubMed ID: 38850402
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
French JA; Chung SS; Krauss GL; Lee SK; Maciejowski M; Rosenfeld WE; Sperling MR; Kamin M
Epilepsia; 2021 Sep; 62(9):2142-2150. PubMed ID: 34254673
[TBL] [Abstract][Full Text] [Related]
19. Cenobamate treatment of focal-onset seizures: Quality of life and outcome during up to eight years of treatment.
Elizebath R; Zhang E; Coe P; Gutierrez EG; Yang J; Krauss GL
Epilepsy Behav; 2021 Mar; 116():107796. PubMed ID: 33567400
[TBL] [Abstract][Full Text] [Related]
20. Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332.
Resnick T; Patten A; Ngo LY; Malhotra M
Epilepsy Behav; 2022 Mar; 128():108528. PubMed ID: 35078116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
